ATE471723T1 - Zusammensetzung zur ophthalmischen verwendung - Google Patents

Zusammensetzung zur ophthalmischen verwendung

Info

Publication number
ATE471723T1
ATE471723T1 AT04730634T AT04730634T ATE471723T1 AT E471723 T1 ATE471723 T1 AT E471723T1 AT 04730634 T AT04730634 T AT 04730634T AT 04730634 T AT04730634 T AT 04730634T AT E471723 T1 ATE471723 T1 AT E471723T1
Authority
AT
Austria
Prior art keywords
ophthalmic solution
hydroxypropylmethylcellulose
molecular weight
present
composition
Prior art date
Application number
AT04730634T
Other languages
English (en)
Inventor
Akira Tsuzuki
Sayuri Iwamuro
Sadayasu Tanikawa
Original Assignee
Menicon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menicon Co Ltd filed Critical Menicon Co Ltd
Application granted granted Critical
Publication of ATE471723T1 publication Critical patent/ATE471723T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
AT04730634T 2003-05-15 2004-04-30 Zusammensetzung zur ophthalmischen verwendung ATE471723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003137828 2003-05-15
PCT/JP2004/005837 WO2004100993A1 (ja) 2003-05-15 2004-04-30 眼科用組成物

Publications (1)

Publication Number Publication Date
ATE471723T1 true ATE471723T1 (de) 2010-07-15

Family

ID=33447269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730634T ATE471723T1 (de) 2003-05-15 2004-04-30 Zusammensetzung zur ophthalmischen verwendung

Country Status (6)

Country Link
US (1) US20060052340A1 (de)
EP (1) EP1623722B1 (de)
JP (1) JP4739022B2 (de)
AT (1) ATE471723T1 (de)
DE (1) DE602004027800D1 (de)
WO (1) WO2004100993A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008152705A1 (ja) * 2007-06-13 2008-12-18 Menicon Co., Ltd. コンタクトレンズ用洗浄シート
JP2009096790A (ja) * 2007-09-28 2009-05-07 Rohto Pharmaceut Co Ltd 疲れ目改善用及び／又はかすみ目改善用コンタクトレンズ装着液
CA3014633C (en) 2007-10-08 2022-05-17 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
US8802075B2 (en) 2009-02-18 2014-08-12 Eyeon Particle Sciences Llc Bi-functional co-polymer use for opthalmic and other topical and local applications
ES2537385T3 (es) * 2009-06-09 2015-06-08 Aurinia Pharmaceuticals Inc. Sistemas de suministro tópico para uso oftálmico
WO2011022736A1 (en) * 2009-08-21 2011-02-24 Belkin International, Inc. Entertainment control system and related methods
WO2011057275A2 (en) * 2009-11-09 2011-05-12 Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University Molecular films for hydrophobic implant surfaces
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP2011207847A (ja) * 2010-03-30 2011-10-20 Nitto Denko Corp フィルム状製剤及びその製造方法
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5587359B2 (ja) * 2012-03-12 2014-09-10 株式会社メニコン コンタクトレンズ用組成物
JP2016501931A (ja) 2012-11-21 2016-01-21 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション，インコーポレーテッドＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｌｏｕｉｓｖｉｌｌｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ，Ｉｎｃ． 酸化的損傷を減じるための組成物および方法
JP5731046B1 (ja) * 2014-05-30 2015-06-10 株式会社メニコン コンタクトレンズ用組成物
JP6530769B2 (ja) * 2015-01-21 2019-06-12 クオリカプス株式会社 インク及びこれを用いた可食体の製造方法並びに可食体の印刷方法
EP3256136A4 (de) 2015-02-09 2018-11-21 University Of Louisville Research Foundation, Inc. Ophthalmische zusammensetzungen und verfahren zur reduzierung von oxidativen schäden einer augenlinse
AU2016413933B2 (en) 2016-07-06 2023-06-15 Calm Water Therapeutics Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
JP4167463B2 (ja) * 1997-05-14 2008-10-15 千寿製薬株式会社 再分散性の良い水性懸濁液剤
AU9186398A (en) * 1997-09-26 1999-04-23 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
JP4848575B2 (ja) * 2000-03-30 2011-12-28 ゼリア新薬工業株式会社 アラントインを配合した安定な液剤
JP2001318348A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ装着液
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
JP4099624B2 (ja) * 2001-04-24 2008-06-11 ライオン株式会社 ソフトコンタクトレンズ用組成物
JP2003183157A (ja) * 2001-12-19 2003-07-03 Lion Corp 眼科用組成物

Also Published As

Publication number Publication date
WO2004100993A1 (ja) 2004-11-25
JPWO2004100993A1 (ja) 2006-07-13
DE602004027800D1 (de) 2010-08-05
EP1623722A4 (de) 2007-03-14
EP1623722B1 (de) 2010-06-23
EP1623722A1 (de) 2006-02-08
JP4739022B2 (ja) 2011-08-03
US20060052340A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
ATE471723T1 (de) Zusammensetzung zur ophthalmischen verwendung
WO2007102053A3 (en) System and method for determining human emotion by analyzing eye properties
ATE534650T1 (de) Neue cyanothiazolide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MX2009006106A (es) Anteojos con dispositivo de barrera para vapor.
TW200700070A (en) Enhanced bimatoprost ophthalmic solution
EA201100393A1 (ru) Применение усиливающих агентов, возможно связанных с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы
CY1112579T1 (el) Μεθοδοι και συνθεσεις για τη διαγνωση του ηλικιακου εκφυλισμου της ωχρας κηλιδας
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
BR9903245A (pt) Lentes de adição progressivas
WO2007103349A3 (en) Devices, methods and compositions for presbyopia correction using ultrashort pulse lasers
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
PL1654002T5 (pl) Kompozycje do dostarczania środków terapeutycznych do oczu
WO2008035246A3 (en) Compositions containing quaternary ammonium compounds
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
ATE547107T1 (de) Verwendung von selenhefe in der behandlung von alzheimers krankheit
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
CL2013002467A1 (es) Composición oftálmica que comprende al menos 0,67% pero no más de 1,0% p/v de olopatadina disuelta en solucion, peg con un peso molecular de 300 a 500, polivinilpirrolidona, hidroxialquil ß-ciclodextrina, hidroxialquil ?-ciclodextrina o su combinación y cloruro de benzalconio; gotario que comprende a la composición oftálmica; y su uso en el tratamiento de la conjuntivitis alérgica ocular.
MY145881A (en) Method for designing spectacle lenses taking into account an individual's head and eye movement
DE602005022286D1 (de) Progressive additionslinsen mit eingestellter bildvergrösserung
ATE423989T1 (de) Progressive brillenlinse
NO20052751L (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
WO2006044425A3 (en) Ophthalmic compositions for treating ocular hypertension
SG157231A1 (en) Substituted p-diaminobenzene derivatives
WO2005020917A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2003105781A3 (en) OPHTHALMIC COMPOSITIONS FOR TREATING EYE HYPERTENSION

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties